Your trusted source for investing success

Tag: GW Pharmaceuticals

Looking for Cannabis Stocks?

Read our report to find market data, important news and stocks to watch!
 
Cannabis ETFs – Should You Invest?

Cannabis ETFs – Should You Invest?

Cannabis stocks can be precarious, but what about cannabis ETFs? Here we look into which cannabis ETFs are in the market and whether or not they are a viable option in cannabis investment.

GW Pharmaceuticals Reports Fiscal First Quarter 2018 Financial Results and Operational Progress

GW Pharmaceuticals (NASDAQ:GWPH) a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces financial results for the first quarter ended 31 December 2017.
As quoted in the press release:

“With the Epidiolex regulatory applications accepted for review in both the US and Europe, and

Alternate Health Launches First Ever Cannabis Blockchain Transaction Ledger

Alternate Health Launches First Ever Cannabis Blockchain Transaction Ledger

 Alternate Health Corp. (“Alternate Health” or the “Company”) (CSE:AHG) (OTC:AHGIF), an international medical cannabis company that uses best-in-class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices, today announced the rebranding of its CanaCard software to the CanaPass

Biotech Players Lead the Growth Charge in the Legal Cannabis Market

Biotech Players Lead the Growth Charge in the Legal Cannabis Market

Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) is a company emerging as a recognizable name within the cannabis space occupied by companies like GW Pharmaceuticals PLC (NASDAQ: GWPH), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), Insys Therapeutics, Inc. (NASDAQ: INSY) and Axim Biotechnologies Inc. (OTCQB: AXIM).

As quoted in the article:
Because the cannabis-biotech sub-sector remains in relative infancy, it is full of

Biotech Stock Up 43% on Cannabis Expansion

Biotech Stock Up 43% on Cannabis Expansion

Revive Therapeutics’ stocks jumped by 43 percent on Thursday after the company announced that it is expanding its product pipeline by developing cannabinoid-based therapeutics specifically for liver diseases.

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Cannabis Weekly Round-Up: Two Provinces Reveal Deals in Place for Recreational Market

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/cannabis-weekly-roundup/